Adcock Ingram Holdings (JSE:AIP) FCF Margin % : 8.57% (As of Jun. 2024)

View and export this data going back to 2008. Start your Free Trial

What is Adcock Ingram Holdings FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Adcock Ingram Holdings's Free Cash Flow for the six months ended in Jun. 2024 was R420 Mil. Adcock Ingram Holdings's Revenue for the six months ended in Jun. 2024 was R4,903 Mil. Therefore, Adcock Ingram Holdings's FCF Margin % for the quarter that ended in Jun. 2024 was 8.57%.

As of today, Adcock Ingram Holdings's current FCF Yield % is 4.58%.

The historical rank and industry rank for Adcock Ingram Holdings's FCF Margin % or its related term are showing as below:

JSE:AIP' s FCF Margin % Range Over the Past 10 Years
Min: 0.89 Med: 3.93 Max: 7.69
Current: 4.53

During the past 13 years, the highest FCF Margin % of Adcock Ingram Holdings was 7.69%. The lowest was 0.89%. And the median was 3.93%.

JSE:AIP's FCF Margin % is ranked better than
60.83% of 993 companies
in the Drug Manufacturers industry
Industry Median: 0.89 vs JSE:AIP: 4.53

Adcock Ingram Holdings FCF Margin % Historical Data

The historical data trend for Adcock Ingram Holdings's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adcock Ingram Holdings FCF Margin % Chart

Adcock Ingram Holdings Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

FCF Margin %

Get a 7-Day Free Trial

5.03

0.89

3.76

2.56

4.53

Adcock Ingram Holdings Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
FCF Margin %	Get a 7-Day Free Trial															4.43	-3.71	9.14	0.35	8.57

Competitive Comparison of Adcock Ingram Holdings's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Adcock Ingram Holdings's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Adcock Ingram Holdings's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Adcock Ingram Holdings's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Adcock Ingram Holdings's FCF Margin % falls into.

Adcock Ingram Holdings FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Adcock Ingram Holdings's FCF Margin for the fiscal year that ended in Jun. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Jun. 2024 )	/	Revenue (A: Jun. 2024 )
	=	437.065	/	9643.128
	=	4.53 %

Adcock Ingram Holdings's FCF Margin for the quarter that ended in Jun. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Jun. 2024 )	/	Revenue (Q: Jun. 2024 )
	=	420.263	/	4902.704
	=	8.57 %

Adcock Ingram Holdings FCF Margin % Related Terms

Thank you for viewing the detailed overview of Adcock Ingram Holdings's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Adcock Ingram Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Adcock Ingram Holdings Ltd (JSE:AIP) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

1 New Road, (c/o New Road & 7th Street), Midrand, Johannesburg, GT, ZAF, 1682

Website

https://www.adcock.com

Adcock Ingram Holdings Ltd is a drug manufacturing company. The company manufactures, markets, and distributes a wide range of healthcare products. The company's reportable segment include Consumer, OTC, Prescription, Hospital and Other-shared services, out of which it generates maximum revenue from Prescription segment. Geographically it operates in Southern Africa and India.